David Gandara shared a post on X:
“Best of WCLC24 in San Francisco.
Joel W. Neal, ‘Sets the Stage’ for the session on targeted therapies.
Fabulous conference highlighting important abstracts from our recent IASLC WCLC.”
Source: David Gandara/X
David Gandara is the Co-Director-Center for Experimental Therapeutics and a professor at UC Davis Comprehensive Cancer Center. His research interests focus on developmental therapeutics of new anti-cancer agents as well as preclinical modeling and clinical research in lung cancer.